igf 1 lr3 subq IGF-1 (1 MG) Unlock the Power of IGF-1

Competing interests The authors have no relevant affiliations or financial involvement with any organization or entity with the financial interest or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed

Progression of liver disease goes from hepatic steatosis, NAFLD, to nonalcoholic steatohepatitis (NASH)

Mitochondrial Defects and Dysfunction in Calcium Regulation in Glaucomatous Trabecular Meshwork Cells

We collected patients clinical and pathological information at the time they were enrolled, including general clinical features (age at diagnosis, height, weight, circulating PSA level), characteristics at surgery (tumor grade, tumor stage, surgical margin status and lymph node involvement) and comorbidities (hypertension, cardiovascular disease and diabetes mellitus)